Detalhe da pesquisa
1.
External validation of a risk model predicting failure of salvage focal ablation for prostate cancer.
BJU Int
; 132(5): 520-530, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37385981
2.
The 'Leucocyte Coping Capacity' test for identifying radiorecurrent prostate cancer: a pilot study.
BJU Int
; 132(3): 268-271, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37169727
3.
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial.
Eur Urol
; 85(1): 35-46, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37778954
4.
Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After Radiotherapy.
Eur Urol
; 81(6): 598-605, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35370021
5.
Corrigendum to "Magnetic Resonance Imaging and targeted biopsies compared to transperineal mapping biopsies prior to salvage focal therapy/ablation in localised and metastatic recurrent prostate cancer after radiotherapy. Primary Outcomes from the FORECAST Trial" [Eur Urol 2022;81(6):598-605].
Eur Urol
; 83(4): e117-e118, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681537